Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BIOFAC A/S is a long-established Danish pharmaceutical and biotechnology company specializing in the production of high-quality biological ingredients for the global healthcare, veterinary, and nutraceutical industries. Founded in 1946, the company focuses on extracting and purifying bioactive compounds from natural animal sources, providing essential active pharmaceutical ingredients (APIs) such as heparin, pancreatin, and thyroid powder. BIOFAC operates multiple state-of-the-art manufacturing facilities in Denmark, all of which comply with international Good Manufacturing Practice (GMP) standards. Their product portfolio supports a wide range of therapeutic areas, including hematology, endocrinology, and gastroenterology. As a key supplier to major pharmaceutical firms, BIOFAC maintains a strong reputation for reliability and biological safety in natural-origin medicinal products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BIOFAC.